| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0009 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |